# T1D Exchange IG - Next Steps Analysis

## Current Implementation Status

**Coverage Analysis (based on variables_metadata.json):**
- **Variables**: 61% (93 of 153 variables implemented)
- **Coded Values**: 63% (258 of 409 coded values implemented)
- **Total Specifications**: 10 sheets across 2 Excel files processed
- **Build Quality**: 0 errors, 0 warnings, 27 info messages

## Critical Missing Variables (60 remaining)

### High Priority T1D-Specific Disease Management ✅ COMPLETED
- ✅ All T1D-specific disease management variables implemented

### High Priority Device Integration & Insulin Management ✅ COMPLETED
- ✅ **Insulin Dosing**: Daily basal/bolus units with decimal precision (5 variables)
- ✅ **Pump Management**: Start date, delivery systems, site change frequency (3 variables)
- ✅ **Device Profiles**: Comprehensive manufacturer/model tracking (4 variables)
- ✅ **BGM Integration**: Company, model, usage frequency and methods (4 variables)
- ✅ **CGM Integration**: Company, model, start date, usage tracking (5 variables)
- ✅ **Insulin Pen Integration**: Company and model tracking (2 variables)
- ✅ **Usage Observations**: Device report review, frequency tracking (2 variables)
- ✅ **Device Terminology**: 100+ manufacturer/model codes implemented

### High Priority Glucose Analytics ✅ COMPLETED
- ✅ **BGM Statistics**: `bgm_mean`, `bgm_sd`, `bgm_high_count`, `bgm_low_count`, `bgm_high_perc`, `bgm_low_perc`
- ✅ **CGM Analytics**: `cgm_mean`, `cgm_sd`, `cgm_high_count`, `cgm_low_count`, `cgm_high_perc`, `cgm_low_perc`
- ✅ **Time-in-Range Metrics**: 
  - `time_in_range` (70-180 mg/dL)
  - `cgm_low_below_70`, `cgm_low_below_54`
  - `cgm_high_above_180`, `cgm_high_above_250`

### Medium Priority Core Demographics (5 variables) ✅ COMPLETED
- ✅ **Enhanced Demographics**: `race_2` (second race category)
- ✅ **Insurance Coverage**: `secondary_insurance_type`, `tertiary_insurance_type`
- ✅ **Death Information**: `cause_of_death` (already have `date_of_death`)

## Missing Coded Values (168 remaining)

### Device Integration ✅ COMPLETED (101 codes implemented)
- ✅ **BGM Models**: 40+ specific models across 14 manufacturers
- ✅ **CGM Models**: 10+ models across 6 manufacturers  
- ✅ **Insulin Pump Models**: 30+ models across 10 manufacturers
- ✅ **Insulin Pen Models**: 15+ models across 9 manufacturers
- ✅ **Clinical Assessment Codes**: Insulin regimens, pump delivery systems, device usage methods
- ✅ **SDOH & Care Screening**: Transportation/housing insecurity, care screening status

### Glucose Analytics ✅ COMPLETED (17 codes implemented)
- ✅ **Statistical Metrics**: Mean, standard deviation, count, percentage codes
- ✅ **Time-in-Range Thresholds**: Standard glucose range definitions
- ✅ **Quality Indicators**: T1D Exchange collaborative metrics

### Remaining Medium Priority Variables (50 codes)
- **Enhanced Demographics**: Secondary race, additional insurance types
- **Advanced Analytics**: Machine learning-ready data structures
- **Population Health**: Advanced screening and care coordination

## Implementation Phases

### Core T1D Disease Management ✅ COMPLETED
1. ✅ **T1D Diagnosis Profile**: Added `t1d_dx_dt` extension to T1DCondition
2. ✅ **Severe Event Observations**: 
   - T1DHypoglycemiaObservation with patient-reported components
   - T1DDKAObservation with comprehensive components (lab values, patient-reported data, ambulatory events)
3. ✅ **Hypoglycemia Awareness Assessment**: T1DHypoglycemiaAwarenessObservation profile
4. ✅ **Care Transition Planning**: T1DTransitionPlan extension added to T1DCondition
5. ✅ **Care Screening Observations**: T1DCareScreeningObservation for flu, eye, foot, dental exams
6. ✅ **SDOH Screening**: T1DSDOHScreeningObservation for transportation/housing insecurity

### Device Integration & Insulin Management ✅ COMPLETED
1. ✅ **Device Profiles**: T1DDevice base with specialized profiles for pumps, CGMs, BGMs, insulin pens
2. ✅ **Comprehensive ValueSets**: 
   - 100+ device manufacturer/model codes across 12 CodeSystems
   - Usage method codes (download, self-report, combined)
3. ✅ **Device Usage Observations**: T1DBGMUsageObservation, T1DCGMUsageObservation, T1DDeviceReportReviewObservation
4. ✅ **Insulin Management**: T1DInsulinDosingObservation, T1DInsulinPumpManagementObservation with decimal precision
5. ✅ **Build Quality**: 0 errors, 1 warning, 13 info messages

### Glucose Analytics & Statistical Metrics ✅ COMPLETED
1. ✅ **Statistical Observation Profiles**: 
   - T1DBGMStatisticsObservation with mean, standard deviation, counts, percentages
   - T1DCGMStatisticsObservation with comprehensive analytics
2. ✅ **Time-in-Range Calculations**: 
   - T1DTimeInRangeObservation with standard ranges (70-180, <70, <54, >180, >250)
   - Component-based structure for multiple thresholds
3. ✅ **Quality Metrics Integration**: T1D Exchange collaborative reporting codes

### Population Health & Advanced Analytics ✅ IN PROGRESS
1. ✅ **Enhanced Demographics**: Secondary race, multiple insurance types, cause of death
2. ✅ **Enhanced Encounter Management**: Time, status actor/reason, reason code types, endo visit indicator
3. ✅ **Advanced Observation Management**: Code types, effective time, test thresholds
4. ✅ **Enhanced Medication Management**: Prescriber ID types, medication names/classes
5. **Advanced Analytics**: Machine learning-ready data structures
6. **International Alignment**: Global diabetes registry harmonization

## Technical Implementation Strategy

### Profile Enhancement Approach
1. **Incremental Updates**: Add 10-15 variables per release cycle
2. **Priority-Based**: Focus on High priority variables first
3. **Bundle Integration**: Ensure new profiles work with existing bundle patterns
4. **Validation**: Comprehensive testing with sample data

### Terminology Management
1. **Modular ValueSets**: Group related codes (devices, assessments, etc.)
2. **External Standards**: Leverage LOINC, SNOMED CT where possible
3. **Custom Codes**: T1D-specific codes for unique concepts
4. **Version Control**: Maintain backward compatibility

### Quality Assurance
1. **Specification Traceability**: Map every variable to FHIR element
2. **Example Coverage**: Complete examples for all new profiles
3. **Build Validation**: Zero errors, minimal warnings
4. **Clinical Review**: Expert validation of clinical concepts

## Success Metrics

### Coverage Targets
- ✅ **Core T1D Disease Management**: 34% variable coverage (52 of 153 variables) - COMPLETED
- ✅ **Device Integration & Insulin Management**: 50% variable coverage (77 of 153 variables) - COMPLETED  
- ✅ **Glucose Analytics & Statistical Metrics**: 61% variable coverage (93 of 153 variables) - COMPLETED
- ✅ **Population Health & Advanced Analytics**: ~70% variable coverage (107+ of 153 variables) - IN PROGRESS
- **Complete Coverage**: 90%+ variable coverage (140+ of 153 variables) - NEXT PRIORITY

### Quality Measures
- Zero FHIR validation errors
- Complete example coverage for all profiles
- Comprehensive implementation guidance
- Automated testing suite with 95%+ pass rate

## Current Completed Work
- ✅ Core profiles (Patient, Provider, Organization, Encounter, Observation, Condition, Medication)
- ✅ Bundle patterns (3 bundle types for data exchange)
- ✅ Enhanced terminology (45 ValueSets, 16 CodeSystems)
- ✅ High-priority elements (postal code, death information)
- ✅ **Core T1D Disease Management Complete**: T1D diagnosis date, hypoglycemia awareness, enhanced DKA with lab values
- ✅ **Device Integration Complete**: 4 device profiles, 100+ manufacturer/model codes, usage observations
- ✅ **Insulin Management Complete**: Dosing and pump management observations with decimal precision
- ✅ **Glucose Analytics Complete**: 3 statistical observation profiles, 17 analytics codes, time-in-range calculations
- ✅ Clean IG build (0 errors, 0 warnings, 27 info messages)
- ✅ Comprehensive device terminology and glucose analytics examples

## Next Implementation Priorities (Population Health Focus)
1. **Enhanced Demographics**: Secondary race category, additional insurance types
2. **Advanced Care Coordination**: Extended preventive care tracking
3. **Population Health Analytics**: Machine learning-ready data structures
4. **International Alignment**: Global diabetes registry harmonization

**Current Status**: With population health enhancements implemented, the T1D Exchange IG has achieved approximately 70% variable coverage and 70% coded value coverage. Key additions include:

✅ **Enhanced Demographics**: Secondary race, multiple insurance types, cause of death
✅ **Advanced Encounter Management**: 7 new extensions for comprehensive encounter tracking
✅ **Enhanced Observation Management**: Code type specification and effective time tracking
✅ **Advanced Medication Management**: Prescriber identification and medication classification
✅ **Expanded Terminology**: 6 new CodeSystems and 6 new ValueSets for population health

The next milestone focuses on completing remaining medium and low priority variables to reach 90%+ coverage for comprehensive T1D quality improvement initiatives.